Literature DB >> 7970839

Serotonin and pain: evidence that activation of 5-HT1A receptors does not elicit antinociception against noxious thermal, mechanical and chemical stimuli in mice.

M J Millan1.   

Abstract

In this study, we examined whether activation of 5-HT1A receptors elicits antinociception in response to acute noxious chemical, thermal and mechanical stimuli in mice. In the writhing test, both agonists (e.g., 8-OH-DPAT, S 14671 and WY 50,324) and partial agonists (e.g., buspirone and gepirone) elicited a pronounced antinociception. However, antagonists (e.g., (-)-alprenolol and WAY 100,135) also induced antinociception and, at lower (inactive) doses, failed to modify the action of agonists. In addition, the separation between doses required for induction of antinociception as compared to those required for induction of ataxia (in the rotarod test) was variable and low for both agonists (median: 1.9) and partial agonists (median: 1.3), although it was somewhat greater for antagonists (> or = 3.3). In the hot-plate test, only certain agonists (e.g., 8-OH-DPAT) and partial agonists (e.g., gepirone) elicited antinociception and their actions were not attenuated by 5-HT1A antagonists which, themselves, were inactive in this paradigm. The 5-HT1C/2 antagonist, ritanserin, the 5-HT3 antagonist, ondansetron, the dopamine D2 receptor antagonist, raclopride, and the alpha 1-adrenoceptor antagonist, prazosin, were also ineffective in modifying the antinociception evoked by 5-HT1A agonists and partial agonists in the hot-plate test. In contrast, their actions were strongly attenuated by the alpha 2-adrenoceptor antagonist, idazoxan. In the tail-flick tests to noxious heat and noxious pressure, 5-HT1A receptor agonists, partial agonists and antagonists generally failed to induce antinociception. Moreover, modulation of stimulus intensity (from very weak to very intense) did not reveal any influence upon the latency to respond. In conclusion, in the writhing test, the data provide no evidence for a specific antinociceptive effect of the activation of 5-HT1A receptors. Further, in the hot-plate test, for those 5-HT1A agonists and partial agonists which induce antinociception, alpha 2-adrenoceptors rather than 5-HT1A receptors are implicated in their actions. Finally, in reflexive tests, irrespective of stimulus quality or intensity, 5-HT1A agonists and partial agonists do not mediate antinociception. These data suggest that the activation of 5-HT1A receptors does not, under these conditions of acute noxious stimulation, elicit antinociception.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7970839     DOI: 10.1016/0304-3959(94)90184-8

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  15 in total

1.  Joint manipulation reduces hyperalgesia by activation of monoamine receptors but not opioid or GABA receptors in the spinal cord.

Authors:  D A Skyba; R Radhakrishnan; J J Rohlwing; A Wright; K A Sluka
Journal:  Pain       Date:  2003-11       Impact factor: 6.961

2.  Potentiation of the antinociceptive effect of clomipramine by a 5-ht(1A) antagonist in neuropathic pain in rats.

Authors:  D Ardid; A Alloui; G Brousse; D Jourdan; P Picard; C Dubray; A Eschalier
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

3.  Effect of intrathecal serotonin on nociception in rats: influence of the pain test used.

Authors:  L Bardin; M Bardin; J Lavarenne; A Eschalier
Journal:  Exp Brain Res       Date:  1997-01       Impact factor: 1.972

4.  Serotonin receptors 5-HT1A and 5-HT3 reduce hyperexcitability of dorsal horn neurons after chronic spinal cord hemisection injury in rat.

Authors:  Bryan C Hains; William D Willis; Claire E Hulsebosch
Journal:  Exp Brain Res       Date:  2003-01-25       Impact factor: 1.972

5.  An opioidergic cortical antinociception triggering site in the agranular insular cortex of the rat that contributes to morphine antinociception.

Authors:  A R Burkey; E Carstens; J J Wenniger; J Tang; L Jasmin
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

6.  Buspirone-induced antinociception is mediated by L-type calcium channels and calcium/caffeine-sensitive pools in mice.

Authors:  Jian-Hui Liang; Xu-Hua Wang; Rui-Ke Liu; Hong-Lei Sun; Xiang-Feng Ye; Ji-Wang Zheng
Journal:  Psychopharmacology (Berl)       Date:  2003-01-28       Impact factor: 4.530

7.  The synergistic interaction between rilmenidine and paracetamol in the writhing test in mice.

Authors:  M Soukupová; T Dolezal; M Krsiak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-02-11       Impact factor: 3.000

8.  Influence of the number and severity of somatic symptoms on the severity of depression and suicidality in community-dwelling elders.

Authors:  Hyun-Ghang Jeong; Changsu Han; Moon Ho Park; Seung-Ho Ryu; Chi-Un Pae; Jun Young Lee; Seung Hyun Kim; David C Steffens
Journal:  Asia Pac Psychiatry       Date:  2014-06-03       Impact factor: 2.538

9.  Decrease in gastric sensitivity to distension by 5-HT1A receptor agonists in rats.

Authors:  M L Rouzade; J Fioramonti; L Bueno
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

10.  Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats.

Authors:  Elaine F Toniolo; Estêfani T Maique; Wilson A Ferreira; Andrea S Heimann; Emer S Ferro; Dinah L Ramos-Ortolaza; Lydia Miller; Lakshmi A Devi; Camila S Dale
Journal:  Peptides       Date:  2014-04-03       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.